日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Drugmakers step up efforts for innovative product R&D

By ZHENG YIRAN | China Daily | Updated: 2020-06-30 09:29
Share
Share - WeChat
Visitors make inquiries at the stand of Bristol-Myers Squibb during the second China International Import Expo in Shanghai on Nov 9, 2019. [Photo/LYU LIANG FOR CHINA DAILY]

Favorable policies spur transformation as profit margins for generic drugs shrink

Pharmaceutical enterprises from home and abroad are stepping up efforts in innovative drug research and development as the domestic innovation environment constantly improves and profit margins for generic drugs gradually shrink, said industry experts.

Zhang Lichao, a senior researcher at Guosen Securities, said both domestic and international pharmaceutical firms in China are undergoing innovative transformation. They have stronger innovation momentum, and have been constantly expanding investment in R&D.

"With favorable policies for innovative drugs and reducing profits for generic drugs, innovation has become the only way for the development of high-quality pharmaceutical enterprises," Zhang said.

On June 11, United States-based biopharmaceutical giant Bristol-Myers Squibb unveiled a new corporate brand in China after its integration with US-based biotech company Celgene in November. BMS also announced its new strategy on the Chinese mainland, in which it plans to introduce up to 30 innovative products or indications to the market in the coming five years, many of which have potential to become first-in-class or best-in-class.

Chen Siyuan, president of BMS Chinese mainland and Hong Kong, said: "BMS has the world's most cutting-edge technology and R&D platform, with leading drug R&D capabilities in three major areas: chemistry, biologics and cell therapy. China is one of BMS' most important R&D, manufacturing, commercial and innovation centers. In the future, we will continue to focus on bringing innovative medicines to patients with cancer and other serious diseases."

In addition, the company is focused on cultivating a culture that encourages and recognizes innovation, and nurturing Chinese executives who have a deep understanding of the market with clear vision and global perspectives.

Domestic pharmaceutical firms are also taking action. Chongqing Pharscin Pharmaceutical Co Ltd announced that it would boost drug innovation, and has introduced a chief science officer, an innovative drug business unit, innovative drug labs and an innovative drug team.

Hangzhou, Zhejiang-province-based Yifan Pharmaceutical Co Ltd also launched a small module chemicals business unit to bring about small module innovative drugs.

A China Securities report showed that in the past five years, among the top-10 frequently used drug categories in Chinese hospitals, innovative drugs are taking an increasing percentage. One supportive policy behind this is the centralized generic drug procurement policy, which effectively lowered generic drug prices and decreased their profit margins. The medical insurance negotiation also sped up the inclusion of innovative drugs into medical insurance reimbursement, promoting the rapid increase of innovative drug penetration.

"These policies made pharmaceutical enterprises' pursuit of an innovation development path an inevitable trend. In the past two years, there was an obvious growth in R&D expenditure in the chemical and pharmaceutical sector," said the report.

In 2019, most of the leading chemical and pharmaceutical enterprises in China increased their R&D investment. The growth rate of R&D spending was higher than that of the sector's overall income, the China Securities report added.

1 2 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 久久久黄色 | 午夜资源站 | 国产在线看片 | 国产免费小视频在线观看 | 精品日韩视频 | 国产精品毛片一区二区三区 | 伊人二本二区 | 一本一本久久α久久精品66 | 色综合久久亚洲国产日韩 | 国产成人av在线 | 成人国产免费观看 | 亚洲日本中文字幕在线2022 | 成人久久免费视频 | 无人精品乱码一区二区三区 | 狠狠骚| www.爱色| 欧美午夜色视频国产精品 | 色噜噜色噜噜天天拍一拍 | 亚洲综合色婷婷久久 | 国产精品久久久久不卡 | 欧美aⅴ片| 最新一区二区三区 | 日本一本久道 | 欧美视频观看 | 丁香六月啪 | 日韩成人免费电影 | 开操网| 国产成人av在线 | 香港三级日本三级韩国a | 99精品国产高清一区二区麻豆 | 日韩女同一区二区三区 | 天天摸天天操天天干 | 日韩日日操 | 草草影院地址 | 农村寡妇偷人高潮A片小说 午夜爱爱爱爱爽爽爽网站免费 | 亚洲一区色 | 毛片99| 日韩精品一区二区电影 | 青青草国产 | 成人无码髙潮喷水A片 | 日日干天天爽 |